ALXO - CIK 0001810182
ALX ONCOLOGY HOLDINGS INC (ALXO) reported revenue of $0.00 for fiscal year 2022, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2022 | $0.00 | - |
| FY 2021 | $0.00 | -100.0% |
| FY 2020 | $1.18M | -75.4% |
| FY 2019 | $4.80M | +132.0% |
| FY 2018 | $2.07M | - |
Between fiscal 2018 and fiscal 2022, ALX ONCOLOGY HOLDINGS INC's revenue declined from $2.07M to $0.00.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.